Further, to explore potential cellular targets for mycoepoxydiene in cervical cancer, Jin found that PGLS was significantly down‐regulated after treatment of mycoepoxydiene, suggesting that PGLS is a potential molecular target of mycoepoxydiene for treatment of cervical cancer.22 This evidence concerns the gene PGLS and cervical cancer.